Biblio Discovery — Demo Discovery Service

24 hasil untuk "Marco Filetti"

Menampilkan 1–20 · 0,58 detik · RSS

  1. Artikel Jurnal

    Motivational intensity and visual word search: Layout matters.

    Marco Filetti; Oswald Barral; Giulio Jacucci dkk.

    PLoS ONE, Vol. 14 No. 7 · 2019 · Inggris · DOAJ Scopus

    Motivational intensity has been previously linked to information processing. In particular, it has been argued that affects which are high in motivational intensity tend to narrow cognitive scope. A similar effect has been attributed to negative affect, which has been linked to narrowing of…

  2. Artikel Jurnal Teks lengkap

    Countering countermeasures: detecting identity lies by detecting conscious breakthrough.

    Howard Bowman; Marco Filetti; Abdulmajeed Alsufyani dkk.

    PLoS ONE, Vol. 9 No. 3 · 2014 · Inggris · DOAJ Scopus

    One major drawback of deception detection is its vulnerability to countermeasures, whereby participants wilfully modulate their physiological or neurophysiological response to critical guilt-determining stimuli. One reason for this vulnerability is that stimuli are usually presented slowly. This…

  3. Artikel Jurnal Teks lengkap

    Subliminal salience search illustrated: EEG identity and deception detection on the fringe of awareness.

    Howard Bowman; Marco Filetti; Dirk Janssen dkk.

    PLoS ONE, Vol. 8 No. 1 · 2013 · Inggris · DOAJ Scopus

    We propose a novel deception detection system based on Rapid Serial Visual Presentation (RSVP). One motivation for the new method is to present stimuli on the fringe of awareness, such that it is more difficult for deceivers to confound the deception test using countermeasures. The proposed system…

  4. Artikel Jurnal Teks lengkap

    Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer Patients

    Rosa Falcone; Pasquale Lombardi; Marco Filetti dkk.

    Current Oncology, Vol. 30 No. 2 · 2023 · Inggris · DOAJ Scopus

    (1) Background: Precision oncology is opening new treatment opportunities for patients suffering from solid tumors. In the last two decades, the advent of CDK4/6 inhibitors, immunotherapy, and antibody–drug conjugates (ADC) improved survival outcomes for advanced or metastatic breast cancers (BC)…

  5. Artikel Jurnal

    Statins and immunotherapy: Togetherness makes strength The potential effect of statins on immunotherapy for NSCLC

    Alessandro Rossi; Marco Filetti; Beatrice Taurelli Salimbeni dkk.

    Cancer Reports, Vol. 4 No. 4 · 2021 · Inggris · DOAJ Scopus

    Abstract Background Recent researches suggested that statins, beside their role in inhibiting endogenous cholesterol synthesis and in cardiovascular prevention, could influence several processes in cancer biology. In fact, a recent meta‐analysis demonstrated that statins could positively influence…

  6. Artikel Jurnal

    Clinical and mutational profile of AT-rich interaction domain 1A-mutated cancers

    Rosa Falcone; Marco Filetti; Pasquale Lombardi dkk.

    Exploration of Targeted Anti-tumor Therapy, Vol. 4 No. 4 · 2023 · Inggris · DOAJ Scopus

    Aim: AT-rich interaction domain 1A (ARID1A) encodes a key component of the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex that participates in gene expression. ARID1A alterations are quite common among cancer patients, although their role remains debated. The aim of this…

  7. Artikel Jurnal

    Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis

    Marco Filetti; Pasquale Lombardi; Rosa Falcone dkk.

    Exploration of Targeted Anti-tumor Therapy, Vol. 4 No. 6 · 2023 · Inggris · DOAJ Scopus

    Aim: This article is based on our previous research, which was presented as a post at the Congress Aiom 2022 Congress and published in Tumori Journal as Conference Abstract (Tumori J. 2022;108:1–194. doi: 10.1177/03008916221114500). In this paper, a comprehensive presentation of all the achieved…

  8. Artikel Jurnal

    CT based radiomic approach on first line pembrolizumab in lung cancer

    Marta Zerunian; Damiano Caruso; Alberto Zucchelli dkk.

    Scientific Reports, Vol. 11 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Clinical evaluation poorly predicts outcomes in lung cancer treated with immunotherapy. The aim of the study is to assess whether CT-derived texture parameters can predict overall survival (OS) and progression-free survival (PFS) in patients with advanced non-small-cell lung cancer (NSCLC)…

  9. Artikel Jurnal

    Current landscape of T-cell engagers in early-phase clinical development in solid cancers

    Andrea Spinazzola; Giovanni Maria Iannantuono; James L. Gulley dkk.

    Frontiers in Immunology, Vol. 16 · 2025 · Inggris · DOAJ Scopus

    T-cell engagers (TCEs) are an emerging class of immunotherapeutic agents designed to harness the immune system to target and eliminate cancer cells. These molecules bridge T lymphocytes with tumor cells, generating an immunologic synapse that leads to potent immune-mediated tumor destruction…

  10. Artikel Jurnal

    Artificial intelligence in oncology publishing: a systematic review and policy analysis of high-impact journals

    Raffaele Giusti; Marco Filetti; Pasquale Lombardi dkk.

    Frontiers in Oncology, Vol. 16 · 2026 · Inggris · DOAJ Scopus

    BackgroundGenerative artificial intelligence (AI) is reshaping scholarly communication, yet guidance for its responsible use remains uneven across biomedical journals. We aimed to systematically assess editorial policies governing AI-assisted writing in high-impact oncology journals.MethodsWe…

  11. Artikel Jurnal

    High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases

    Marta Laganà; Cristina Gurizzan; Elisa Roca dkk.

    Frontiers in Oncology, Vol. 10 · 2020 · Inggris · DOAJ Scopus

    ObjectivesThe prevalence of Skeletal Related Adverse Events (SREs) in EGFR mutated non-small cell lung cancer (NSCLC) patients with bone metastases, treated with modern tyrosine kinase inhibitors (TKIs), has been scarcely investigated.Materials and MethodsWe retrospectively evaluated the data of…

  12. Artikel Jurnal

    Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes

    Gennaro Ciliberto; Raffaele Giusti; Marco Filetti dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 8 No. 2 · 2020 · Inggris · DOAJ Scopus

    Background Immune checkpoint inhibitors (ICIs) provide significant survival benefits in non-small cell lung cancer (NSCLC). Nevertheless, while some patients obtain a prolonged benefit, a non-negligible fraction of patients experiences an ultrarapid disease progression. Identifying specific…

  13. Artikel Jurnal

    Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice

    Alessandro Russo; Paolo Antonio Ascierto; Alessio Cortellini dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 8 No. 2 · 2020 · Inggris · DOAJ Scopus

    Background Concomitant medications, such as steroids, proton pump inhibitors (PPI) and antibiotics, might affect clinical outcomes with immune checkpoint inhibitors.Methods We conducted a multicenter observational retrospective study aimed at evaluating the impact of concomitant medications on…

  14. Artikel Jurnal

    A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable

    Alessio Cortellini; Melissa Bersanelli; Sebastiano Buti dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 7 No. 1 · 2019 · Inggris · DOAJ Scopus

    Abstract Background Recent evidence suggested a potential correlation between overweight and the efficacy of immune checkpoint inhibitors (ICIs) in cancer patients. Patients and methods We conducted a retrospective study of advanced cancer patients consecutively treated with anti-PD-1/PD-L1…

  15. Artikel Jurnal

    High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status

    Alessio Cortellini; Raffaele Giusti; Marco Filetti dkk.

    Journal of Hematology & Oncology, Vol. 15 No. 1 · 2022 · Inggris · DOAJ Scopus

    Abstract Family history of cancer (FHC) is a hallmark of cancer risk and an independent predictor of outcome, albeit with uncertain biologic foundations. We previously showed that FHC-high patients experienced prolonged overall (OS) and progression-free survival (PFS) following PD-1/PD-L1…

  16. Artikel Jurnal

    Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study

    Alessio Cortellini; Sebastiano Buti; Melissa Bersanelli dkk.

    OncoImmunology, Vol. 9 No. 1 · 2020 · Inggris · DOAJ Scopus

    Background: We investigate the role of family history of cancer (FHC) and diagnosis of metachronous and/or synchronous multiple neoplasms (MN), during anti-PD-1/PD-L1 immunotherapy. Design: This was a multicenter retrospective study of advanced cancer patients treated with anti-PD-1/PD-L1…

  17. Artikel Jurnal

    PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort

    Daniele Santini; Tea Zeppola; Marco Russano dkk.

    Journal of Translational Medicine, Vol. 19 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Background The favourable safety profile and the increasing confidence with immune checkpoint inhibitors (ICIs) might have boosted their prescription in frail patients with short life expectancies, who usually are not treated with standard chemotherapy. Methods The present analysis aims to…

  18. Artikel Jurnal

    INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2)

    Diana Giannarelli; Sandro Pignata; Vincenzo Montesarchio dkk.

    Journal for ImmunoTherapy of Cancer, Vol. 9 No. 5 · 2021 · Inggris · DOAJ Scopus

    Background Until now, no robust data supported the efficacy, safety and recommendation for influenza vaccination in patients with cancer receiving immune checkpoint inhibitors (ICIs).Methods The prospective multicenter observational INfluenza Vaccine Indication During therapy with Immune checkpoint…